News Archive

The rectal cancer program at Hollings has earned accreditation from the National Accreditation Program for Rectal Cancer.

A new study by Hollings researchers shows that more than 60% of U.S. adults who vape are interested in quitting.

Technology developed by Hollings researchers can detect early-stage liver cancer at double the rate of current tools.

Cokie Cox's Mount Everest climb is generating awareness and funding for cancer prevention and outreach at Hollings.

Experts at Hollings and MUSC Health addressed a range of topics surrounding COVID-19 vaccination and cancer patients.

Registration opens March 24 for LOWVELO, Hollings' annual bike ride to raise money for lifesaving cancer research.

Hollings is partnering with the Talbot family to bring a state affiliate of the Pancreatic Cancer Action Network to South Carolina.

The first annual LOWVELO Symposium will focus on building a successful career in cancer research for trainees at all levels.

How do viruses mutate? How do vaccines keep up? Dr. Danielle Scheurer explains in this week's Q&A.

Dr. Danielle Scheurer talks about hugging, sequencing and variants in this week's COVID vaccine Q&A.